Femara arimidex

Femara - Letrozole Tablets What is this medication? LETROZOLE (LET roe zole) treats some types of breast cancer. It works by decreasing the amount of estrogen hormone your body makes, which slows or stops breast cancer cells from spreading or growing. Learn about side effects, cost, uses, and more of Femara (letrozole), which is a prescription drug that treats breast cancer in certain females. The dose of Femara in patients with cirrhosis and severe hepatic dysfunction should be reduced by 50% [see Warnings and Precautions (5.3)]. The recommended dose of Femara for such patients is. Femara tablets for oral administration contains 2.5 mg of letrozole, a nonsteroidal aromatase inhibitor (inhibitor of estrogen synthesis). It is chemically described as. Find patient medical information for Letrozole (Femara) on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings Drug Summary What Is Femara? Femara (letrozole) is a non-steroidal aromatase inhibitor (lowers estrogen production) used to treat breast cancer in postmenopausal women. Femara is often given to women who have been taking tamoxifen (Nolvadex, Soltamox) for 5 years. Femara is available in generic form. What Are Side Effects of Femara? Femara (letrozole) is a brand-name prescription drug used for certain types of breast cancer. Learn about side effects, off-label use for infertility, and more. “I’m on my third year of Femara and am tolerating it well. I categorize my side effects as ‘inconsistent and somewhat annoying.’ For example; I have sporadic instances of calf and arch cramps; intense sweating, joint pain and stiffness — but never all at once and not day after day. Femara lowers estrogen levels and is used to treat breast cancer in postmenopausal women. Learn about side effects, interactions and indications. Femara is a treatment that may be used to reduce the risk of breast cancer recurrence in postmenopausal women and also to increase the chance of ovulation in women with polycystic ovary syndrome.

Meta: